To include your compound in the COVID-19 Resource Center, submit it here.

Representatives investigating rising MS prices

Reps. Elijah Cummings (D-Md.) and Peter Welch (D-Vt.) launched an investigation into the rising price of multiple sclerosis drugs, citing increases in price of as much as 1002% over the lifetime of a drug despite growing competition. The committee issued a press release Thursday containing letters sent to Bayer AG (Xetra:BAYN), Biogen Inc. (NASDAQ:BIIB), Merck KGaA

Read the full 567 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE